Prathyusha Konda
Prathyusha Konda
Postdoc at Dana-Farber Cancer Institute & Harvard Medical School
Verified email at DFCI.HARVARD.EDU - Homepage
Cited by
Cited by
Transition metal complexes and photodynamic therapy from a tumor-centered approach: challenges, opportunities, and highlights from the development of TLD1433
S Monro, KL Colon, H Yin, J Roque III, P Konda, S Gujar, RP Thummel, ...
Chemical reviews 119 (2), 797-828, 2018
ALDH1A3-regulated long non-coding RNA NRAD1 is a potential novel target for triple-negative breast tumors and cancer stem cells
D Vidovic, TT Huynh, P Konda, C Dean, BM Cruickshank, M Sultan, ...
Cell Death & Differentiation 27 (1), 363-378, 2020
Near-infrared absorbing Ru (II) complexes act as immunoprotective photodynamic therapy (PDT) agents against aggressive melanoma
LM Lifshits, JA Roque III, P Konda, S Monro, HD Cole, D von Dohlen, ...
Chemical science 11 (43), 11740-11762, 2020
MHC-I ligand discovery using targeted database searches of mass spectrometry data: implications for T-cell immunotherapies
JP Murphy, P Konda, DJ Kowalewski, H Schuster, D Clements, Y Kim, ...
Journal of Proteome Research 16 (4), 1806-1816, 2017
Cytokines in oncolytic virotherapy
JG Pol, ST Workenhe, P Konda, S Gujar, G Kroemer
Cytokine & Growth Factor Reviews 56, 4-27, 2020
RTN4 knockdown dysregulates the AKT pathway, destabilizes the cytoskeleton, and enhances paclitaxel-induced cytotoxicity in cancers
GP Pathak, R Shah, BE Kennedy, JP Murphy, D Clements, P Konda, ...
Molecular Therapy 26 (8), 2019-2033, 2018
Multiplexed relative quantitation with isobaric tagging mass spectrometry reveals class I major histocompatibility complex ligand dynamics in response to doxorubicin
JP Murphy, Q Yu, P Konda, JA Paulo, MP Jedrychowski, DJ Kowalewski, ...
Analytical chemistry 91 (8), 5106-5115, 2019
Inhibition of Pyruvate Dehydrogenase Kinase Enhances the Antitumor Efficacy of Oncolytic ReovirusOncolytic Reovirus in Combination with PDH Reprogramming
BE Kennedy, JP Murphy, DR Clements, P Konda, N Holay, Y Kim, ...
Cancer research 79 (15), 3824-3836, 2019
Therapy-induced MHC I ligands shape neo-antitumor CD8 T cell responses during oncolytic virus-based cancer immunotherapy
JP Murphy, Y Kim, DR Clements, P Konda, H Schuster, DJ Kowalewski, ...
Journal of proteome research 18 (6), 2666-2675, 2019
Closely related reovirus lab strains induce opposite expression of RIG-I/IFN-dependent versus-independent host genes, via mechanisms of slow replication versus polymorphisms in …
A Mohamed, P Konda, HE Eaton, S Gujar, JR Smiley, M Shmulevitz
PLoS Pathogens 16 (9), e1008803, 2020
Discovery of immunogenic cell death-inducing ruthenium-based photosensitizers for anticancer photodynamic therapy
P Konda, LM Lifshits, JA Roque III, HD Cole, CG Cameron, SA McFarland, ...
Oncoimmunology 10 (1), 1863626, 2021
Quantitative temporal in vivo proteomics deciphers the transition of virus-driven myeloid cells into M2 macrophages
DR Clements, JP Murphy, A Sterea, BE Kennedy, Y Kim, E Helson, ...
Journal of proteome research 16 (9), 3391-3406, 2017
Photodynamic therapy of melanoma with new, structurally similar, NIR-absorbing ruthenium (II) complexes promotes tumor growth control via distinct hallmarks of immunogenic cell …
P Konda, JA Roque III, LM Lifshits, A Alcos, E Azzam, G Shi, CG Cameron, ...
American Journal of Cancer Research 12 (1), 210, 2022
Immune checkpoint blockade augments changes within oncolytic virus-induced cancer MHC-I peptidome, creating novel antitumor CD8 T cell reactivities
Y Kim, P Konda, JP Murphy, JA Paulo, SP Gygi, S Gujar
Molecular & Cellular Proteomics 21 (2), 2022
Neuronal mitochondrial calcium uniporter deficiency exacerbates axonal injury and suppresses remyelination in mice subjected to experimental autoimmune encephalomyelitis
SP Holman, AS Lobo, RJ Novorolsky, M Nichols, MDJ Fiander, P Konda, ...
Experimental Neurology 333, 113430, 2020
Genetic polymorphisms and molecular mechanisms mediating oncolytic potency of reovirus strains
A Mohamed, DR Clements, P Konda, SA Gujar, PW Lee, JR Smiley, ...
bioRxiv, 569301, 2019
Improving MHC‐I Ligand Identifications from LC‐MS/MS Data by Incorporating Allelic Peptide Motifs
P Konda, JP Murphy, S Gujar
Proteomics 19 (5), 1800458, 2019
Enhancing mass spectrometry-based MHC-I peptide identification through a targeted database search approach
P Konda, JP Murphy, M Nielsen, S Gujar
Immunoproteomics: Methods and Protocols, 301-307, 2019
NAD+ depletion enhances reovirus-induced oncolysis in multiple myeloma
BE Kennedy, M Giacomantonio, JP Murphy, S Cutler, M Sadek, P Konda, ...
Molecular Therapy-Oncolytics 24, 695-706, 2022
Improving MHC-I ligand identification by incorporating targeted searches of mass spectrometry data
P Konda, JP Murphy, S Gujar
Bioinformatics for Cancer Immunotherapy: Methods and Protocols, 161-171, 2020
The system can't perform the operation now. Try again later.
Articles 1–20